How Can Scientists and Investigators Find Funding Today?
June 24th 2025Rodney Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc, discusses the ongoing concerns around the federal government’s hold on funding for research and the potential chilling effect that it may have on laboratory professionals and deciding upon careers, especially in areas such as public health. He also talks about locating and engaging in potential alternative resources for research funding.
Considering the Value of Antiviral Resistance Testing in Certain Populations
June 23rd 2025At ASM Microbe 2025, Meghan Starolis, PhD, discusses her presentation on antiviral testing including the advantages and limitations to genotypic and phenotypic testing and looking at how this can affect the immunocompromised population.
ASM Microbe Conference: 'Great Migration of Microbiologists'
June 22nd 2025American Society for Microbiology (ASM) CEO Stefano Bertuzzi, PhD, MPH, talks about its comprehensive scientific program, the networking opportunities at the meeting, and the unique format it plans to roll out for the 2026 conference.
Bloodstream Infections in Ethiopia Reveal High Rates of Multidrug Resistance and Fungal Involvement
June 20th 2025At ASM Microbe 2025, a cross-sectional study highlights Burkholderia cepacia dominance, widespread antibiotic resistance, and key risk factors, including invasive device use and patient demographics.
Considering the Impact of Crop Spraying and Antifungal Resistance
June 20th 2025At the ASM Microbe conference, Mike Bromley, PhD, offers some insights on the importance of a One Health approach addressing the growing antifungal resistance to azoles and Aspergillus fumigatus because of the connection between crop spraying and the rise of resistance.
CDC Reverses Layoffs, Restores Critical Hepatitis and STI Labs Amid Public Health Concerns
Published: June 17th 2025 | Updated: June 17th 2025After initially closing its viral hepatitis and sexually transmitted disease laboratories, the CDC rescinds staff terminations, preserving vital disease surveillance and outbreak response capabilities.
A Passion for Infectious Disease Education and Communication
In our latest podcast, Tim Gauthier, PharmD, BCPS, BCIDP, discusses all things pathogens and antibiotics. He also details the opportunities presented for antimicrobial stewardship when it combines diagnostics and treatment duration.
Professional Societies Must Address Gaps When Politics Overrides Evidence
June 16th 2025In an early release of his letter for the Summer issue, Editor-in-Chief Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, discusses the recent changes to the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP), and where professional societies must step in and lead with research data and clinical guidance in the absence of experienced committee members.
FDA Expands Indication for AbbVie’s Antiviral as First Treatment for People With Acute Hepatitis C
June 13th 2025The antiviral, glecaprevir/pibrentasvir (Mavyet), is the first and only oral 8-week pangenotypic treatment approved for people with acute or chronic hepatitis C. The approval supports global clinical guidelines to advance testing and treatment of HCV regardless of chronicity and supports public health goals for disease elimination.
The Lingering Threat: Managing Severe COVID-19 in the Postpandemic Era
June 12th 2025Although COVID-19 has receded quite a bit from the minds of many, it still remains a virus that can present serious morbidity and mortality. Here is a review of clinical treatment strategies by an intensivist when seeing patients with severe COVID-19.